Northwestern University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Northwestern University sits in the top decile of US sponsors by registered trial count (#23 of 15,742 sponsors by registered trial count).
Northwestern University: 1,209 sponsored US clinical trials, 187 recruiting.
Northwestern University sponsors 1,209 registered US clinical trials on ClinicalTrials.gov, 187 of them currently recruiting, and 767 completed. 114 of these trials are in Phase 3-4 (later-stage) and 295 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 11 trials.
Top-decile sponsor footprint
Northwestern University ranks in the top decile of sponsors by registered trial count (#23 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
767 of 912 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,209 total, page 10 of 25
Prenatal Depression Prevention Effects on Parenting and Young Child Self-Regulation and Functioning
NCT04296734
(SGB) in Men Treated for Prostate Cancer Improve Hot Flashes
NCT03796195
Pre-SunBeam TEWL AUC
NCT04226092
The EMPATHY Pilot Study
NCT04384848
Chest Dysphoria in Transmasculine Spectrum Adolescents
NCT04195659
A Pragmatic Trial of Two Strategies for Implementing an Effective eHealth HIV Prevention Program (Keep It Up! 3.0)
NCT03896776
Esophageal Temperature Management During Cryo AF Ablation (EnsoETM)
NCT04079634
A Randomized Controlled Trial of Geriatric Emergency Department Innovations
NCT04115371
Effects of Device-assisted Practice of ADL on Arm/Hand Recovery in Individuals With Moderate to Severe Stroke
NCT04077073
A Research Study for Latina Women Undergoing Breast Cancer Treatment
NCT04064151
Remote Microphone Candidacy Study
NCT03897634
Affective and Cognitive Responses to Acute Bouts of Physical Activity and Mindfulness Training
NCT04078464
Plan to Thrive: Extending Cancer Survivorship Care Beyond the Clinic
NCT03996031
Abemaciclib and Letrozole in Treating Patients With Endometrial Cancer
NCT04049227
Deliberate Ultraviolet Light Exposure to Get a Tan by Young Adult Sexual Minority Males
NCT04404907
Evaluation of a Symptom and Needs Assessment for Patients With Cancer
NCT04014751
Promoting Healthy Brain Development: Wellness for 2 Study
NCT05052281
IntelliCare in College Students
NCT04035577
Cost and Quality in Consumer Sunscreen Preferences
NCT04016441
Weekly Steroids in Muscular Dystrophy
NCT04054375
The Effects of Metreleptin in Congenital Leptin Deficiency
NCT04063488
Early Communication Intervention for Toddlers With Hearing Loss
NCT03803943
Comparing Proficiency of Laparoscopic Vaginal Cuff Suturing After Laparoscopic Training in Surgically Naive Students
NCT04524988
ICG to Assess Ovarian Perfusion
NCT03927651
A Web-Based Tool to Improve Breast Cancer Survivorship
NCT03849573
Measuring the Neurological Benefits of Intermittent Hypoxia Therapy With MRI
NCT05183113
Development of a FES Device for Hand Use During Arm Activities Following Stroke
NCT03986216
Optimizing Quality of Life in Women Living With Metastatic Breast Cancer
NCT04374825
Methacetin Breath Test in Patients With Liver Disease Secondary to Heart Disease
NCT04176458
Wearable Skin Sensors to Assess Nocturnal Scratch Behavior
NCT03770858
CCU Wireless Vital Signs Monitoring
NCT04142073
Maximizing Outcomes for Preschoolers With Developmental Language Disorders
NCT03782493
Diagnostic Ultrasound for Measuring Fat of the Body
NCT03871556
Combination Chemotherapy and TAK-659 as Front-Line Treatment in Treating Patients With High-Risk Diffuse Large B Cell Lymphoma
NCT03742258
M-POWER Feasibility Study
NCT05921565
Expressive Helping for Stem Cell Transplant Patients
NCT03800758
Spoken Discourse Biomarker of PD Cognitive Impairment
NCT05909163
Effectiveness and Implementation of a Mindfulness Intervention for Depressive Symptoms Among Adults in a FQHC
NCT03620721
Development and Evaluation of an Electronic Health Record-based Medication Complete Communication (EMC2) Strategy
NCT03652272
Nivolumab and Yttrium-90 in Treating Patients With Liver Cancer Undergoing Surgical Resection
NCT03812562
fMRI Study of tES in Major Depression
NCT04031547
Minimally Invasive Burch Colposuspension to Reduce Occult Stress Incontinence
NCT03841513
Use of Erythropoietin to Expand Regulatory T Cells in Autoimmune Liver Disease
NCT03842254
Reactive Standing Balance Step Training Post Stroke
NCT05772936
Behavioral Economics Applications to Geriatrics Leveraging EHRs
NCT03704389
Sweat and Gas Sensor for Healthy Skin and Atopic Dermatitis
NCT03874039
The "PC-LIGHT" Study
NCT03419585
Psychosocial Adjunctive Treatment for Hypersomnia (PATH)
NCT03904238
Characterization of Lipoprotein Composition and Function in Pediatric Psoriasis Before and After Treatment
NCT03791216
The Effect of Walking on Frailty
NCT03654807
What is open in the Northwestern University pipeline
187 recruiting of 1,209 indexed (15% open); 767 completed (63%).
Phase mix: 114 late (III/IV) vs 295 early (I/II) (early-phase heavy).
Top condition: Depression (11 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Northwestern University: open-pipeline peers nationwide
Peers matched on 1,209 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,209 trials (± recruiting share)
- Emory University · 1,208 trials · 17% recruiting
- University of Pittsburgh · 1,238 trials · 13% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Brigham and Women's Hospital · 15% recruiting · 937 trials
- Incyte Corporation · 15% recruiting · 239 trials
- Nationwide Children's Hospital · 15% recruiting · 188 trials
- University of Michigan Rogel Cancer Center · 15% recruiting · 292 trials
Related
What to do with this Northwestern University page
1,209 registered trials is a research-attention snapshot, not an endorsement of Northwestern University or any single study.
- 187 of Northwestern University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition Northwestern University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Northwestern University pipeline card: 1,209 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.